Santarus files $75 million shelf

By Ted A. Knutson

Washington, May 12 - Santarus, Inc. filed a $75 million shelf in an S-3 registration with the Securities and Exchange Commission.

The filing allows the company to issue common and preferred stock, debt securities and convertibles.

The San Diego-based wire and pharmaceutical company said offerings authorized by the shelf would be used to support sales and marketing relating to Zegerid Powder for Oral Suspension and the anticipated commercialization of Zegerid Capsules and Zegerid Chewable Tablets, to fund research and development activities and to fund other working capital and general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.